Here are the DEF 14A proxy statements from Adient plc (ADNT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ADNT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADNT filings page.
Adient plc is asking shareholders to vote on key governance and compensation matters at its 2026 Annual General Meeting on March 10, 2026 in Dublin, Ireland. Shareholders will elect eight directors for one-year terms, ratify PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 (and authorize the Board, through the Audit Committee, to set audit fees), and cast an advisory vote on named executive officer pay.
Investors are also asked to renew the Board’s authority under Irish law to issue shares and to opt out of statutory preemption rights, with the latter requiring at least 75% of votes cast and being conditional on approval of the issuance authority. The meeting will receive and consider Irish Statutory Accounts for the year ended September 30, 2025. The Board, which has an independent chair and seven independent directors out of eight, highlights its risk oversight framework, committee structure, ethics and insider trading policies, and sustainability focus.
The proxy explains how to vote, broker voting rules, and deadlines for submitting director nominations and shareholder proposals for the 2027 meeting. It also describes the company’s pay-for-performance philosophy, noting that a large majority of executive compensation is variable and tied to financial and strategic goals, and that Adient repurchased $125 million of shares in fiscal 2025, about 6.1 million shares or 7% of shares outstanding at the start of the year.